Investor Presentaiton slide image

Investor Presentaiton

sanofi Ambitious program with first pediatric PCV20+ vaccine; clear blockbuster potential Phase 3 starts in H1 2024 Expected submission in 2027 Initiating development of next generation PCV21+ vaccines 68 Vaccines Investor Event
View entire presentation